Cystic Fibrosis and Fit-to-Fly

CompletedOBSERVATIONAL
Enrollment

79

Participants

Timeline

Start Date

March 1, 2019

Primary Completion Date

January 31, 2023

Study Completion Date

January 31, 2023

Conditions
Cystic FibrosisHypoxemiaLung Diseases
Interventions
OTHER

Pre-flight evaluation

All the participants receive the interventions as part of their routine medical care during their annual visit for CF follow-up. Oxygen saturation are measured by pulse oximetry. Exercise testing is performed by 6MWT and CPET. Pre-flight evaluation is performed by HAST.

Trial Locations (1)

0407

Oslo University Hospital Ullevaal, Department of Pulmonary Medicine, Oslo

All Listed Sponsors
collaborator

The Norwegian Resouce Centre for Cystic Fibrosis

UNKNOWN

collaborator

Norwegian National Adivisory Unit on Rare Disorders

UNKNOWN

collaborator

University Hospital, Akershus

OTHER

lead

Oslo University Hospital

OTHER

NCT03843723 - Cystic Fibrosis and Fit-to-Fly | Biotech Hunter | Biotech Hunter